Home / Letter From The Editor / Oct. 24, 2020

Oct. 24, 2020

Oct 24, 2020
 

When George McConnell, PharmD. Candidate, LECOM School of Pharmacy, was in our rotation, he had to review patients using CGM devices to manage their diabetes. He learned very quickly how patients could take advantage of the devices to improve their Time In Range (TIR). This is very quickly becoming the standard of measuring success in diabetes management, especially when compared to traditional A1c readings. While the A1c gives an average, CGM locates the extremes that contribute to the average, and gives patients the ability to improve their TIR.

This week, George brings us the results of a 3 year study that shows why more of our patients should be on CGM.

 

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief